FOR IMMEDIATE RELEASE
FOR ADDITIONAL INFORMATION, CALL
Marita Gomez, 630-936-9105
ANiGENT adds to its Board of Advisors with three senior executives from financial firms
St. Louis, Mo., Nov. 24, 2020 — Fast-growing company ANiGENT has brought on three more executives to serve on its Board of Advisors. Mike Thaman, Tom Tilley and Tony Giordano will sit on the board and offer insights that will help the company finetune its future, accelerating ANiGENT’s growth trajectory.
ANiGENT is the first and only software provider to deliver a comprehensive solution that helps facilities track and monitor potential drug diversion among all users and all drugs in all locations. Its proprietary drug diversion prevention software is the result of a collaboration with Mayo Clinic.
“We’re elated to welcome these outstanding individuals to our board of advisors,” said V.C. “Jun” Fabella, Jr., chief executive officer and managing partner of ANiGENT. “Their unique expertise will help us shape our business strategies while continuing to help healthcare facilities keep patients safe by preventing drug diversion from occurring.”
Mike Thaman is co-founder and managing partner of Warson Capital Partners, an investment banking firm that focuses on sourcing capital for growth companies as well as buy-side and sell-side mergers and acquisition transactions. Thaman’s specialty areas include healthcare services, medical instruments, specialty retailing, automotive dealerships, banking, national defense, and manufacturing.
Tom Tilley is a managing director at Mariner Capital Advisors and leads the firm’s 10-person investment banking team. With more than 15 years of investment banking experience, Tilley assists business owners and private equity firms in acquiring and divesting privately held businesses around the country. Tilley manages all aspects of business transactions including sourcing buyers and sellers, financial modeling, building capital structures, negotiating and closing the transactions.
Tony Giordano is an accomplished executive, experienced at combining excellent analytical skills with pragmatic judgment to positively contribute to best in class productivity and profit in both startup and growth organizations. Currently, Giordano serves as a partner for B&N Inspection and Supply, TEN21 Capital and Store House Investments.
“In 2021, our plan is to bring all members of the Board of Advisors to meet, strategize and plan our path forward,” said Fabella.
# # #
ANiGENT, the result of a collaborative partnership with the Mayo Clinic, is a new company that delivers a comprehensive, patent-pending solution based on Medication Administration & Analysis Program (MAAP). Created by chief product officer and managing partner Charles D’Amato, MAAP Analytics uses machine learning to deliver a state-of-the-art drug diversion surveillance system. For more information, visit: anigent.com.